Ignite Creation Date:
2024-05-06 @ 2:57 PM
Last Modification Date:
2024-10-26 @ 1:40 PM
Study NCT ID:
NCT04476797
Status:
TERMINATED
Last Update Posted:
2024-04-30
First Post:
2020-07-15
Brief Title:
Phase III Study of SBRT and GC4711 for Centrally Located or Large NSCLC
Sponsor:
Galera Therapeutics Inc
Organization:
Galera Therapeutics Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-10-18
Start Date Type:
ACTUAL
Primary Completion Date:
2023-11-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-11-28
Completion Date Type:
ACTUAL
First Submit Date:
2020-07-15
First Submit QC Date:
July 15 2020
Study First Post Date:
2020-07-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2024-04-03
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-02
Last Update Post Date:
2024-04-30
Last Update Post Date Type:
ACTUAL